These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5800170)

  • 1. [On the treatment of peripheral arterial circulatory disorders].
    Heide M
    Hippokrates; 1969 May; 40(9):354-7. PubMed ID: 5800170
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prolonged intra-arterial infusion in the treatment of decompensated arterial obstructions in the extremities].
    Michal V
    Bull Soc Int Chir; 1969; 28(3):383-6. PubMed ID: 5400559
    [No Abstract]   [Full Text] [Related]  

  • 3. The arteriolar effects of cinnarizine and flunarizine. Multitechnical investigations in normal volunteers and in patients with occlusive disease of the extremities secondary to arteriosclerosis.
    Verhaegen H; Roels V; Adriaensen H; Brugmans J; De Cock W; Dony J; Jageneau A; Schuermans V
    Angiology; 1974 Apr; 25(4):261-78. PubMed ID: 4818724
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug therapy of arteriosclerotic circulatory disorders].
    Nobbe F
    Z Allgemeinmed; 1974 Jul; 50(21):957-64. PubMed ID: 4152664
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long term treatment of arteriosclerotically induced circulatory disorders of the retina and choroid with vitamins A + E as well as a nicotinic acid derivative].
    Kager S
    Klin Monbl Augenheilkd; 1968; 153(4):571-7. PubMed ID: 4975191
    [No Abstract]   [Full Text] [Related]  

  • 6. [The therapy of peripheral circulatory disorders (angiooganopathies) with a blood extract].
    Schirren C; Dietrich K; Biel F
    Hautarzt; 1967 Jun; 18(6):260-4. PubMed ID: 5593511
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oscillographic results of the treatment of peripheral circulatory disorders with Theo-Esberiven].
    Akdeniz H
    Med Welt; 1970 Aug; 34():1469-72. PubMed ID: 5510408
    [No Abstract]   [Full Text] [Related]  

  • 8. [The valve of intra-arterial perfusion of low molecular weight dextran, vasodilating drugs and heparin in arterial disease of the lower extremities].
    Mercier C; Juhan C
    Ann Chir; 1968 May; 22(9):661-6. PubMed ID: 5684563
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prognosis of the length of remission following conservative treatment of atherosclerotic occlusions of the main arteries of the extremities].
    Shishkin EK; Shcherbiuk AN; Ginzburg LS; Lemenev VL; El'kov AN
    Sov Med; 1988; (11):65-7. PubMed ID: 3238515
    [No Abstract]   [Full Text] [Related]  

  • 10. [Objective evaluation of the Lamuran effect using electronic oscillography and oscillometry].
    Nusser E; Eberl R
    Med Welt; 1968 Nov; 44():2414-20. PubMed ID: 5729449
    [No Abstract]   [Full Text] [Related]  

  • 11. [Arteriosclerotic peripheral circulation disorders. Pathophysiology of arteriosclerotic peripheral circulation disorders and their management].
    Mörl H
    ZFA (Stuttgart); 1979 Mar; 55(8):469-78. PubMed ID: 425668
    [No Abstract]   [Full Text] [Related]  

  • 12. [Management of peripheral arterial blood circulation disorders during stay at a health resort].
    Hervatin C; Münster B
    Med Monatsschr; 1967 Mar; 21(3):131-2. PubMed ID: 5594898
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment with L-arginine is likely to stimulate generation of nitric oxide in patients with peripheral arterial obstructive disease.
    Gryglewski RJ; Grodzińska L; Kostka-Trabka E; Korbut R; Bieroón K; Goszcz A; Sławiński M
    Wien Klin Wochenschr; 1996; 108(4):111-6. PubMed ID: 8867484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of peripheral arteriosclerotic circulation disorders with sex hormones].
    Meng W; Meng S
    Z Arztl Fortbild (Jena); 1968 Dec; 62(24):1306-9. PubMed ID: 5714204
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the effect of (diethyl-amino-ethoxy-carbonyl) 3 pyridine (Soclidan) in arterial circulatory disorders of the lower extremities].
    Ockenga T; Ozer M
    Ther Ggw; 1965 Dec; 104(12):1639-53. PubMed ID: 5887060
    [No Abstract]   [Full Text] [Related]  

  • 16. [Study of the general tolerance of Naftidrofuryl in daily intra-arterial perfusions].
    Tingaud R; Massé C; Faure L; Fischer
    Bord Med; 1970 Nov; 3(11):2797-801 passim. PubMed ID: 5510152
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical controlled experimentation of a combination of a peripheral vasodilator agent and a clarifying and hypolipemic agent].
    Nicrosini F; Butti A; Pasotti C
    Farmaco Prat; 1969 Mar; 24(3):157-66. PubMed ID: 4238678
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of Tebonin in peripheral arterial circulatory disorders].
    Franke G; Maxis M
    Med Monatsschr; 1969 Mar; 23(3):128-30. PubMed ID: 5779072
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of transdermal nitroglycerin on inflammatory mediators in patients with peripheral atherosclerotic vascular disease.
    de Berrazueta JR; Sampedro I; Garcia-Unzueta MT; Llorca J; Bustamante M; Amado JA
    Am Heart J; 2003 Oct; 146(4):E14. PubMed ID: 14564337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Problems of intra-arterial injection therapy in peripheral circulatory disorders. II].
    Reichel H; Weinberger T
    Med Welt; 1967 Sep; 37():2202-10. PubMed ID: 5612666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.